Zobrazeno 1 - 10
of 1 194
pro vyhledávání: '"J M, Gaillard"'
Autor:
Arjan D van Zuilen, Stefan P Berger, Wayel H Abdulahad, Michele F Eisenga, Jacoba M Spikman, Martin H de Borst, P van der Meer, Carlo A J M Gaillard, Stephan JL Bakker, Joanna SJ Vinke, Jan-Stephan F Sanders
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction Iron deficiency (ID) is common and has been associated with an excess mortality risk in kidney transplant recipients (KTRs). In patients with chronic heart failure and ID, intravenous iron improves exercise capacity and quality of life.
Externí odkaz:
https://doaj.org/article/17c56f0774864728a60e453cff977945
Autor:
Johanna Kuipers, Jurjen K. Oosterhuis, Wolter Paans, Wim P. Krijnen, Carlo A. J. M. Gaillard, Ralf Westerhuis, Casper F. M. Franssen
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background There is increasing awareness that, besides patient survival, Quality of Life (QOL) is a relevant outcome factor for patients who have a chronic disease. In haemodialysis (HD) patients, intradialytic hypotension (IDH) is considere
Externí odkaz:
https://doaj.org/article/e78a833876c34a10bdec5f635dc3766e
Autor:
A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard, Esther Meijer, on behalf of the DIPAK Consortium
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Somatostatin (SST) inhibits intracellular cyclic adenosine monophosphate (cAMP) production and thus may modify cyst formation in autosomal dominant polycystic kidney disease (ADPKD). We investigated whether endogenous plasma SST c
Externí odkaz:
https://doaj.org/article/5ffdb32fedf24b4aa7465562d43628c9
Autor:
Jesse M. G. Hofman, Michele F. Eisenga, Adry Diepenbroek, Ilja M. Nolte, Bastiaan van Dam, Ralf Westerhuis, Stephan J. L. Bakker, Casper F. M. Franssen, Carlo A. J. M. Gaillard
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Although the efficacy of iron sucrose (IS) and ferric carboxymaltose (FCM) in treating anemia in hemodialysis (HD) patients has been studied individually, a comparison of these two intravenous iron formulations has not yet been pe
Externí odkaz:
https://doaj.org/article/fff6c37198b74854a2722e7fbb25c7e2
Autor:
Michele F. Eisenga, Ilja M. Nolte, Peter van der Meer, Stephan J. L. Bakker, Carlo A. J. M. Gaillard
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Iron deficiency is highly prevalent in chronic kidney disease (CKD) patients. In clinical practice, iron deficiency is defined based on a combination of two commonly used markers, ferritin and transferrin saturation (TSAT). Howeve
Externí odkaz:
https://doaj.org/article/f21f4d05477347cbaadf358341e9ed2f
Autor:
Esmée M. Ettema, Johanna Kuipers, Martijn van Faassen, Henk Groen, Arie M. van Roon, Joop D. Lefrandt, Ralf Westerhuis, Ido P. Kema, Harry van Goor, Ron T. Gansevoort, Carlo A. J. M. Gaillard, Casper F. M. Franssen
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-12 (2018)
Abstract Background Intradialytic hypotension is a common complication of hemodialysis. The Hemocontrol biofeedback system, improving intradialytic hemodynamic stability, is associated with an initial transient increase in plasma sodium levels. Incre
Externí odkaz:
https://doaj.org/article/5eb9ce313b4a4026b26ff2b310c2ad75
Autor:
E. Quéméré, J. M. Gaillard, M. Galan, C. Vanpé, I. David, M. Pellerin, P. Kjellander, A. J. M. Hewison, J. M. Pemberton
Publikováno v:
BMC Evolutionary Biology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Understanding the genetic and environmental mechanisms governing variation in morphology or phenology in wild populations is currently an important challenge. While there is a general consensus that selection is stronger under str
Externí odkaz:
https://doaj.org/article/05c3a800dc1d4d4ba253edd47ce83ba1
Autor:
Bernardo Faria, Mariana Gaya da Costa, Felix Poppelaars, Casper F. M. Franssen, Manuel Pestana, Stefan P. Berger, Mohamed R. Daha, Carlo A. J. M. Gaillard, Marc A. Seelen
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Intravenous (IV) iron is widely used to treat anemia in chronic kidney disease patients. Previously, iron formulations were shown to induce immune activation in-vitro. The current study aimed to investigate the effect of IV iron on comple
Externí odkaz:
https://doaj.org/article/ec90782f091c4087a079b935839ff343
Autor:
Michele F. Eisenga, Mireille E. Emans, Karien van der Putten, Maarten J. Cramer, Adry Diepenbroek, Birgitta K. Velthuis, Pieter A. Doevendans, Marianne C. Verhaar, Jaap A. Joles, Stephan J. L. Bakker, Ilja M. Nolte, Branko Braam, Carlo A. J. M. Gaillard
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 16 (2019)
Background In patients with chronic heart failure and chronic kidney disease, correction of anemia with erythropoietin‐stimulating agents targeting normal hemoglobin levels is associated with an increased risk of cardiovascular morbidity and mortal
Externí odkaz:
https://doaj.org/article/baf6c377b3794abc9b1eaaa51c0774c2
Autor:
Michele F Eisenga, Maarten A De Jong, Peter Van der Meer, David E Leaf, Gerwin Huls, Ilja M Nolte, Carlo A J M Gaillard, Stephan J L Bakker, Martin H De Borst
Publikováno v:
PLoS Medicine, Vol 16, Iss 6, p e1002818 (2019)
BackgroundEmerging data in chronic kidney disease (CKD) patients suggest that iron deficiency and higher circulating levels of erythropoietin (EPO) stimulate the expression and concomitant cleavage of the osteocyte-derived, phosphate-regulating hormo
Externí odkaz:
https://doaj.org/article/aebb6109169b46568c9d687a6be506ec